Ticker Details
XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.
IPO Date:	July 1, 1986
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$319.61M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.11%
Avg Daily Range (30 D):	$0.76 | 2.88%
Avg Daily Range (90 D):	$0.73 | 2.53%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	115
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	394
Avg Institutional Trade:	$1.65M
Avg Institutional Trade (30 D):	$1.15M
Avg Institutional Trade (90 D):	$1.06M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.52M
Avg Closing Trade (30 D):	$1.15M
Avg Closing Trade (90 D):	$1.06M
Avg Closing Volume:	73.4K

News

Feb 9, 2026 @ 2:53 PM XOMA Royalty Announces Closing of Tender Offer and... Source: Globe Newswire

Jan 20, 2026 @ 9:47 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 22, 2025 @ 12:30 PM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire

Dec 15, 2025 @ 10:00 PM XOMA Royalty Enters into Agreement to Acquire Gene... Source: Globe Newswire

Dec 5, 2025 @ 12:45 PM Mural Oncology Announces Effectiveness of Scheme o... Source: Globe Newswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.81	$.74
Diluted EPS	$.75	$.7
Revenue	$47.11M	$9.35M
Gross Profit
Net Income / Loss	$21.64M	$14.05M	$9.19M
Operating Income / Loss	$1.95M	$-1.33M
Cost of Revenue
Net Cash Flow	$-16.26M
PE Ratio	36.05

Splits
Oct 18, 2016	1:20
Aug 18, 2010	1:15